ADAPY · Adaptimmune Therapeutics
Adaptimmune Therapeutics plc engages in research, development, and subsequent manufacture and commercialisation of cell therapies to treat cancer in the United States and the United Kingdom. The company was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
Market Cap
7.952M
52 Wk Range
$0.00 - $0.24
Previous Close
$0.03
Open
$0.03
Volume
77,399
Day Range
$0.03 - $0.03
Enterprise Value
29.51M
Cash
26.06M
Avg Qtr Burn
-34.78M
Insider Ownership
0.63%
Institutional Own.
0.00%
Qtr Updated
Jun 30th 2025